A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo
The lack of animal models for some human diseases precludes our understanding of disease mechanisms and our ability to test new therapies in vivo. Here the authors present a tissue bioengineering strategy for the study of a rare kidney tumor called angiomyolipoma, in vitro and in vivo, using patient...
Enregistré dans:
Auteurs principaux: | J. O. R. Hernandez, X. Wang, M. Vazquez-Segoviano, M. Lopez-Marfil, M. F. Sobral-Reyes, A. Moran-Horowich, M. Sundberg, D. O. Lopez-Cantu, C. K. Probst, G. U. Ruiz-Esparza, K. Giannikou, R. Abdi, E. P. Henske, D. J. Kwiatkowski, M. Sahin, D. R. Lemos |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/928c67a16e704b9e921c20f97413c1e4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Bioengineering
Publié: (2014) -
Corneal reconstruction by stem cells and bioengineering
par: Arjamaa O
Publié: (2012) -
Recent Advances in Kidney Bioengineering
par: Nina Cintron Pregosin, et autres
Publié: (2021) -
Bioengineering the spider silk sequence to modify its affinity for drugs
par: Kucharczyk K, et autres
Publié: (2018) - AIMS bioengineering